MedTrace Logo

End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)

NCT00792974 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 199

Last updated 2009-02-05

No results posted yet for this study

Summary

The aim of the study is to develop an interview to ask patients with COPD about their fear of death and dying, their needs and wishes at the end-of-life. Afterwards, the patients receive a brief psychological intervention to develop coping strategies for chronic illness. Beside this a general purpose of this intervention is to improve patients' quality of life.

Conditions

Interventions

BEHAVIORAL

A brief psycho-educational intervention

A brief (3 single sessions) psycho-educational program with cognitive-behavioral and disease self-management techniques. This study is an open pilot study ("feasibility study") to develop a palliative psychological program for end-of-life fears in COPD, therefore all participants will be given the opportunity to receive treatment.

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Philipps University Marburg

    lead OTHER

Principal Investigators

  • Winfried Rief, Prof. Dr. · Department of Clinical Psychology and Psychotherapy, Philipps University Marburg, Germany

  • Klaus Kenn, Dr. · Klinikum Berchtesgadener Land, Schön Kliniken, Schönau a. K., Germany

  • Sabine R Pinzer, Dipl.-Psych. · Department of Clinical Psychology and Psychotherapy, Philipps University Marburg, Germany

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00792974 on ClinicalTrials.gov